Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure
Erin M. Schumer(University of Louisville), Allen Cheng(Australian Regenerative Medicine Institute), Mark S. Slaughter(University of Louisville), Jaimin R. Trivedi(University of Louisville), Mickey S. Ising(St. Elizabeth Healthcare)
Cited by 34
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
The Epidemiology and Clinical Spectrum of Melioidosis: 540 Cases from the 20 Year Darwin Prospective Study
|PLoS neglected tropical diseases|2010|759
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757